Sites

  • Global
  • USA
  • English
  • Latin America
  • Germany
  • France
  • Spain
  • Italy
  • Portugal
  • Turkey

References - USA

  1. Lacroix S, Schwetz N, Pritchard A, Mulder K, Zourikian N. All About Inhibitors. Montreal, Canada: Canadian Hemophilia Society; 2003. http://www.hemophilia.ca/files/All%20About%20Inhibitors.pdf. Accessed October 4, 2018.
  2. Giangrande P. Acquired hemophilia. In: Mahlangu J, ed. Treatment of Hemophilia. Montreal, Canada: World Federation of Hemophilia; 2012. http://www1.wfh.org/publication/files/pdf-1186.pdf. Published November 2012. Accessed October 4, 2018.
  3. Hemophilia of Georgia. The Hemophilia, von Willebrand Disease & Platelet Disorders Handbook. https://www.hog.org/handbook. Accessed October 4, 2018.
  4. Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al; Treatment Guidelines Working Group on Behalf of The World Federation of Hemophilia. Guidelines for the management of hemophilia. 2nd ed. Haemophilia. 2013;19(1):e1-e47.
  5. Leissinger CA. Advances in the clinical management of inhibitors in hemophilia A and B. Semin Hematol. 2016;53(1):20-27.
  6. National Hemophilia Foundation. Facts about inhibitors. New York, NY: National Hemophilia Foundation; 2017. https://www.hemophilia.org/sites/default/files/document/files/Facts-About-Inhibitors.pdf. Accessed October 4, 2018.
  7. Rivard GE, Blanchette V, Hilliard P, Mulder K, Zourikian N. Management of bleeds. In: Amesse C, Bedard L, Blanchette V, et al, eds. All About Hemophilia. 2nd ed. Montreal, Canada: Canadian Hemophilia Society; 2010.
  8. Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications. Lancet. 2016;388(10040):187-197.
  9. National Heart, Lung and Blood Institute. Hemophilia. https://www.nhlbi.nih.gov/health-topics/hemophilia. Accessed October 4, 2018.
  10. Page D, Amesse C, Zereik H. An introduction to hemophilia. In: Amesse C, Bedard L, Blanchette V, et al, eds. All About Hemophilia. 2nd ed. Montreal, Canada: Canadian Hemophilia Society; 2010.
  11. Koerper MA, Stang D. Caring for Your Child With Hemophilia. New York, NY: National Hemophilia Foundation; 2001. https://www.hemophilia.org/sites/default/files/document/files/Caring%20for%20Your%20Child.pdf. Accessed October 4, 2018.
  12. Morris C. The Emergency Room: Prepare to Succeed. Montreal, Canada: Canadian Hemophilia Society; 2012. http://www.hemophilia.ca/files/er2.pdf. Accessed June 13, 2017.
  13. Rivard GE, Meilleur C, Hilliard P, Mulder K. Complications of hemophilia. In: Amesse C, Bedard L, Blanchette V, et al, eds. All About Hemophilia. 2nd ed. Montreal, Canada: Canadian Hemophilia Society; 2010.
  14. Buzzard B, Beeton K, eds. Physiotherapy Management of Haemophilia. London, UK: Blackwell Science; 2000.
  15. Riley RR, Witkop M, Hellman E, Akins S. Assessment and management of pain in haemophilia patients. Haemophilia. 2011;17(6):839-845.
  16. Hum D. Challenges, Choices, Decisions: A Guide on Orthopedic Surgery for People with Hemophilia and Inhibitors. Montreal, Canada: Canadian Hemophilia Society; 2010. http://www.hemophilia.ca/files/Challenges-Choices-Decisions%20Hemophilia.pdf. Accessed October 4, 2018.
  17. Collins PW, Chalmers E, Hart DP, et al; UK Haemophilia Centre Doctors. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. Br J Haematol. 2013;160(2):153-170.
  18. World Federation of Hemophilia. What Are Inhibitors? Montreal, Canada: World Federation of Hemophilia; 2009. http://www1.wfh.org/publication/files/pdf-1343.pdf. Accessed October 4, 2018.
  19. Franchini M, Mannucci PM. Non-factor replacement therapy for haemophilia: a current update. Blood Transfus. 2018;16(5):457-461.
  20. MASAC recommendation on administration of inhibitor bypassing agents in the home for patients with hemophilia and inhibitors. MASAC Document #233. National Hemophilia Foundation website. https://www.hemophilia.org/sites/default/files/document/files/233HomeAdministration.pdf. Accessed October 4, 2018.
  21. Srivastava A, Giangrande P, Poon MC, et al; Treatment Guidelines Working Group on Behalf of The World Federation of Hemophilia. Guidelines for the Management of Hemophilia. Montreal, Canada: World Federation of Hemophilia; 2005.
  22. Kulkarni R. Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspects. Haemophilia. 2013;19(1):2-10.
  23. Santagostino E, Escobar M, Ozelo M, et al. Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors. Blood Rev. 2015;29(suppl 1):S9-S18.
  24. Creighton K, Maze A, Stain AM. Growing with hemophilia. In: Amesse C, Bedard L, Blanchette V, et al, eds. All About Hemophilia. 2nd ed. Montreal, Canada: Canadian Hemophilia Society; 2010. http://www.hemophilia.ca/files/GFFchap9.pdf. Accessed October 4, 2018.
  25. Anderson A, Forsyth A. Playing It Safe: Bleeding Disorders, Sports and Exercise. New York, NY: National Hemophilia Foundation; 2017.
  26. US Department of Health and Human Services, US Department of Agriculture. 2015-2020 Dietary Guidelines for Americans. 8th ed. http://health.gov/dietaryguidelines/2015/guidelines/. Published December 2015. Accessed October 4, 2018.
  27. Omega-3 fatty acids. University of Maryland Medical Center website. https://www.umms.org/ummc/patients-visitors/health-library/medical-encyclopedia/images/omega3-fatty-acids. Accessed October 4, 2018.
  28. Schulman S. Drugs that can cause bleeding. World Federation of Hemophilia website. https://www.wfh.org/en/page.aspx?pid=639. Updated February 2010. Accessed June 9, 2017.
  29. World Federation of Hemophilia. Tips for Travelers. https://www.wfh.org/en/page.aspx?pid=902. Updated May 2012. Accessed October 4, 2018.